Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
GLS-1200
DRUG
2 trials
Sponsors
GeneOne Life Science, Inc.
Conditions
Infection
SARS-CoV 2
Sinusitis Chronic
Phase 2
GLS-1200 Topical Nasal Spray to Prevent Sinusitis After Endoscopic Sinus Surgery
NCT04060316
GeneOne Life Science, Inc.
Sinusitis Chronic
Start: 2023-12-31
End: 2024-09-30
Target: 99
Updated: 2023-01-11
GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19)
Terminated
NCT04408183
GeneOne Life Science, Inc.
Infection, SARS-CoV 2
Start: 2020-06-10
End: 2023-01-10
Updated: 2025-07-31